Fang, Lanyan
152  Ergebnisse:
?
7

Use of physiologically‐based pharmacokinetic modeling to un..:

Tan, Ming‐Liang ; Gao, Zongming ; Babiskin, Andrew...
CPT: Pharmacometrics & Systems Pharmacology.  13 (2023)  2 - p. 247-256 , 2023
 
?
9

Regulatory utility of physiologically‐based pharmacokinetic..:

Wu, Fang ; Mousa, Youssef ; Raines, Kimberly...
CPT: Pharmacometrics & Systems Pharmacology.  12 (2023)  5 - p. 585-597 , 2023
 
?
10

Increasing impact of quantitative methods and modeling in e..:

Yoon, Miyoung ; Babiskin, Andrew ; Hu, Meng...
CPT: Pharmacometrics & Systems Pharmacology.  12 (2023)  5 - p. 552-555 , 2023
 
?
11

Evaluation of model‐based bioequivalence approach for singl..:

Tardivon, Coralie ; Loingeville, Florence ; Donnelly, Mark...
CPT: Pharmacometrics & Systems Pharmacology.  12 (2023)  7 - p. 904-915 , 2023
 
?
12

Regulatory utility of physiologically based pharmacokinetic..:

Al Shoyaib, Abdullah ; Riedmaier, Arian Emami ; Kumar, Anita...
CPT: Pharmacometrics & Systems Pharmacology.  12 (2023)  5 - p. 610-618 , 2023
 
?
13

Regulatory utility of mechanistic modeling to support alter..:

Babiskin, Andrew ; Wu, Fang ; Mousa, Youssef...
CPT: Pharmacometrics & Systems Pharmacology.  12 (2023)  5 - p. 619-623 , 2023
 
?
14

Establishing the suitability of model‐integrated evidence t..:

Gong, Yuqing ; Zhang, Peijue ; Yoon, Miyoung...
CPT: Pharmacometrics & Systems Pharmacology.  12 (2023)  5 - p. 624-630 , 2023
 
?
15

Quantitative methods and modeling to assess COVID‐19‐interr..:

Gong, Yuqing ; Feng, Kairui ; Zhang, Peijue...
CPT: Pharmacometrics & Systems Pharmacology.  11 (2022)  7 - p. 833-842 , 2022
 
1-15